Amoxapine: Research, Dosing, and Where to Buy in 2026
A research-first profile for Amoxapine (amoxapine), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Amoxapine is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, and 1 attributed expert mention for Amoxapine, each linked to its source.
- Also indexed as amoxapine.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Amoxapine?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Experts on background and overview · 1 cited mention
"a combination of something like a nootropic, amoxapine, and a stimulant I think that goes a long way."
Amoxapine Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy Amoxapine in 2026
No tracked vendor recommendations for Amoxapine yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
What Experts Say
1 expert across our source library discuss Amoxapine. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.
-
“a combination of something like a nootropic, amoxapine, and a stimulant I think that goes a long way.”
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Amoxapine. Each line links to the original source.
- "516 (44·4%) participants were female and 422 (36·3%) were male; sex data were not available for the other 223 (19·2%)." · Oliva V et al, 2024 PubMed
- "489 (42·1%) participants were White, 47 (4·0%) were African American, and 12 (1·0%) were Asian; race or ethnicity data were not available for the other 613 (52·8%)." · Oliva V et al, 2024 PubMed
- "Only the combination of fluoxetine plus olanzapine was associated with a higher proportion of participants with a treatment response compared with placebo (risk ratio 1·91 [95% CI 1·27-2·85]), with no differences in terms of safety outcomes compared with placebo." · Oliva V et al, 2024 PubMed
- "Amoxapine is widely distributed throughout body tissues and is 90% bound to serum proteins." · Kinney J et al, 1982 PubMed
- "Side effects noted during amoxapine therapy include hypotension (42%), drowsiness (14%), xerostomia (14%), constipation (12%), blurred vision (7%), fatigue (5%), and vertigo (5%)." · Kinney J et al, 1982 PubMed
Research and Studies
8 PubMed-indexed papers reference Amoxapine. Top 8 shown.
Legal Status
Amoxapine is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Amoxapine FDA-approved?
Amoxapine is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on Amoxapine?
8 PubMed-indexed paper(s) reference Amoxapine in our current research feed. See the Research and Studies section above for citations.